Vasculearn Network
VLN illustration of atrial fibrillation
Atrial Fibrillation (AFib)

The Good, The Bad, and The Ugly of Atrial Fibrillation

February 16, 2022 1 min read

Dr. Steven Deitelzweig discusses opportunities for improving anticoagulant management, an evidence-based risk assessment, how pivotal trials and guidelines are used to select oral anticoagulants (OAC). He also provides information on selecting the right OAC for patients, how to manage bleeding events on a OAC, and strategies for an effective transition of care.

Find more of your people.

Join the conversations that matter to you.